{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:58:37Z","timestamp":1762459117726},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>We report here a case of partial response to hepatic arterial infusion chemotherapy in a patient who developed serious hepatic failure due to unresectable colorectal cancer and hepatic metastasis and showed resistance to systemic chemotherapy with molecular targeted drugs, mFOLFOX6, and FOLFIRI. The patient was a 60-year-old woman who underwent sigmoidectomy for sigmoid colon cancer, lateral posterior hepatic segmentectomy for metastatic liver cancer, and postoperative radiation therapy for metastatic lung cancer. As first-line systemic chemotherapy, mFOLFOX6 (oxaliplatin, 5-fluorouracil, and leucovorin), bevacizumab\u2009+\u2009FOLFIRI (irinotecan, 5-fluorouracil, leucovorin), and anti-epidermal growth factor receptor antibody\u2009+\u2009irinotecan were administered, in that order. However, recurrent hepatic metastasis was exacerbated, which induced serious hepatic failure manifested by general malaise, jaundice, abnormal hepatic function, difficulty in walking due to bilateral lower extremity edema, and decreased appetite. The patient was admitted in a serious condition. After hospitalization, the patient received hepatic arterial infusion chemotherapy with 5-fluorouracil and l-leucovorin. After two complete courses, the symptoms improved. The patient\u2019s performance status also improved, and she was discharged from the hospital. Four months after discharge, the patient had continued outpatient chemotherapy and maintained excellent performance status. Although HAIC is not presently considered an alternative to systemic chemotherapy, it is sometimes effective in patients who show resistance to molecular targeted drug therapy, FOLFOX, and FOLFIRI, and in whom hepatic metastasis is a key factor in determining prognosis and serious hepatic failure. Further studies should be performed in the future to verify these findings.<\/jats:p>","DOI":"10.1186\/1477-7819-11-203","type":"journal-article","created":{"date-parts":[[2013,8,17]],"date-time":"2013-08-17T16:14:22Z","timestamp":1376756062000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Partial response after transcatheter arterial infusion chemotherapy in a patient with systemic chemotherapy-resistant unresectable colon cancer and hepatic metastasis: (case report)"],"prefix":"10.1186","volume":"11","author":[{"given":"Katsuji","family":"Sawai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Goi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Koneri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanji","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,17]]},"reference":[{"key":"1394_CR1","volume-title":"JSCCR Guidelines 2010 for the Treatment of Colorectal Cancer","author":"Japanese Society for Cancer of the Colon and Rectum","year":"2010","unstructured":"Japanese Society for Cancer of the Colon and Rectum: JSCCR Guidelines 2010 for the Treatment of Colorectal Cancer. 2010, Tokyo: Kanehara Co, Ltd"},{"key":"1394_CR2","unstructured":"National Cancer Institute-Common toxicity criteria, NCI-CTC Version2.0: April 30, 1999"},{"key":"1394_CR3","volume-title":"General rules for clinical and pathological studies on cancer of the colon. Rectum and anus","author":"Japanese Society for Cancer of the Colon and Rectum","year":"1998","unstructured":"Japanese Society for Cancer of the Colon and Rectum: General rules for clinical and pathological studies on cancer of the colon. Rectum and anus. 1998, Tokyo: Kanehara & Co, Ltd, 6","edition":"6"},{"key":"1394_CR4","volume-title":"JSCCR Guidelines for Colorectal Cancer Treatment","author":"Japanese Society for Cancer of the Colon and Rectum","year":"2005","unstructured":"Japanese Society for Cancer of the Colon and Rectum: JSCCR Guidelines for Colorectal Cancer Treatment. 2005, Tokyo: Kanehara & Co, Ltd, 1","edition":"1"},{"key":"1394_CR5","unstructured":"NCCN Clinical Practice Guidelines in Oncology. Antiemesis: V.2.2010.http:\/\/www.nccn.org\/professionals\/physician-gls\/PDF\/antiemesis,"},{"key":"1394_CR6","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1159\/000332937","volume":"27","author":"T Goi","year":"2011","unstructured":"Goi T, Sawai K, Koneri K, Katayama K, Yamaguchi A: Results of hepatic arterial infusion chemotherapy in patients with unresectable liver metastases. Viszeralmedizin. 2011, 27: 397-401. 10.1159\/000332937.","journal-title":"Viszeralmedizin"},{"key":"1394_CR7","doi-asserted-by":"publisher","first-page":"5649","DOI":"10.1200\/JCO.2007.12.1764","volume":"25","author":"M Simone","year":"2007","unstructured":"Simone M, Pierluigi P, Mario L, Donato N: Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era?. J Clin Oncol. 2007, 25: 5649-5654. 10.1200\/JCO.2007.12.1764.","journal-title":"J Clin Oncol"},{"key":"1394_CR8","first-page":"3045","volume":"30","author":"Y Chen","year":"2010","unstructured":"Chen Y, Yan Z, Wang J, Wang X, Luo J, Liu Q: Hepatic arterial infusion with oxaliplatin, irinotecan and doxifluridine for unresectable liver metastases of colorectal cancer. Anticancer Res. 2010, 30: 3045-3049.","journal-title":"Anticancer Res"},{"key":"1394_CR9","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.1200\/JCO.2008.20.1301","volume":"27","author":"NE Kemeny","year":"2009","unstructured":"Kemeny NE, Huitzil Melendez FD, Capanu M, Paty PB, Fong Y, Schwartz LH, Jarnagin WR, Patel D, D\u2019Angelica M: Conversion to respectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma. J Clin Oncol. 2009, 27: 3465-3471. 10.1200\/JCO.2008.20.1301.","journal-title":"J Clin Oncol"},{"key":"1394_CR10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1245\/s10434-007-9581-7","volume":"15","author":"V Boige","year":"2008","unstructured":"Boige V, Malka D, Elias D, Castaing M, De Baere T, Goere D, Dromain C, Pocard M, Ducreux M: Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure. Ann Surg Oncol. 2008, 15: 219-226. 10.1245\/s10434-007-9581-7.","journal-title":"Ann Surg Oncol"},{"key":"1394_CR11","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1093\/annonc\/mdm405","volume":"18","author":"DJ Gallagher","year":"2007","unstructured":"Gallagher DJ, Capanu M, Raggio G, Kemeny N: Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: a retrospective analysis. Ann Oncol. 2007, 18: 1995-1999. 10.1093\/annonc\/mdm405.","journal-title":"Ann Oncol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7819-11-203.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T01:00:56Z","timestamp":1630544456000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/1477-7819-11-203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,17]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1394"],"URL":"https:\/\/doi.org\/10.1186\/1477-7819-11-203","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,17]]},"assertion":[{"value":"6 March 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"203"}}